GSK's Advil Dual Action in Combination with Acetaminophen Receives the US FDA's Approval for Pain Relief
Shots:
- The approval is based on seven clinical studies including three of which were pivotal efficacy and safety studies in pain relief which involves assessing of ibuprofen (250 mg) + acetaminophen (500 mg) vs ibuprofen and acetaminophen monothx in patients with acute pain symptoms
- The study demonstrated that the FD combination achieved superior efficacy then the monotherapy in patients
- Advil Dual Action is combination of ibuprofen and acetaminophen resulting to an exclusive pain reliever and will be available over-the-counter nationwide in 2020
Click here to read full press release/ article
Ref: PRNewswire | Image: GSK
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com